David Scadden, Director at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 200 shares at $46.28 ($9K) on 2024-12-11, disclosed to the SEC on 2024-12-13.
Scheduled sale ($9k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AGIO | SELL | 2025-10-02 | $8K | — | Filing → |
| AGIO | SELL | 2025-08-29 | $8K | — | Filing → |
| AGIO | SELL | 2025-07-15 | $56K | — | Filing → |